2022 Life sciences regulatory outlook has been saved
Perspectives
2022 Life sciences regulatory outlook
Navigating key trends in life sciences regulatory compliance
Gain industry insight into key regulations and get updates on what companies should be tracking and addressing in 2022 and beyond.
Explore content
- Life sciences regulations in 2021
- Expand to read
- More life sciences trends and insights
- Get in touch
- Join the conversation
2021 Life sciences regulatory outlook
Over the past several years, life sciences companies have faced mounting pressure from many directions, including increasing regulatory requirements, nonstop technological advances, and intense pricing pressure. And the unprecedented events in recent years have only provided more reason to modernize compliance and elevate the value and partnerships within your companies and external stakeholders.
To continue thriving and leading, life sciences companies must continue to meet the industry’s new challenges head-on. Now is the ideal time for the compliance function to evolve its focus from hindsight to foresight.
In the 2021 regulatory outlook, the overarching theme was for life sciences companies to take a closer look at their compliance activities. Download the report to see how companies can make compliance an integral part of their overall business strategy.
More life sciences trends and insights
- Read Deloitte's 2021 global life sciences outlook for insights on how life sciences companies continue to respond to the impacts of the pandemic and in what areas they can build resilience going forward
- Learn why, in the future of health, engaging with regulators and staying abreast of legislative and regulatory activity will be more important than ever for life sciences organizations
- Understand how pharma and medtech can shift from doing digital to being digital
- Gain insights into how AI is already helping to improve process efficiency in the life sciences industry
Get in touch
 Paul Silver Principal Deloitte & Touche LLP psilver@deloitte.com +1 404 631 215 |
 Jack Tanselle Managing director Deloitte & Touche LLP jtanselle@deloitte.com +1 317 656 2452 |
 Marcy Imada Managing director Deloitte & Touche LLP mimada@deloitte.com + 1 213 553 1642 |
 Clarissa Crain Managing director Deloitte & Touche LLP ccrain@deloitte.com +1 717 669 6090 |
Recommendations
Regulatory changes in the future of health
Engaging with regulators and staying abreast of legislative and regulatory activity will be as important as ever
The modernization of life sciences compliance
A proactive approach to regulations
